A new vaccine that boosts immunity against tuberculosis (TB) has been shown to be effective in pioneering pre-clinical trials.

A new mRNA vaccine against tuberculosis (TB) is showing favorable results in preclinical trials. With only one currently ...

A new vaccine that boosts immunity against tuberculosis (TB) has been shown to be effective in pioneering pre-clinical trials ...

Tuberculosis (TB) is a serious infectious disease caused by the bacterium Mycobacterium tuberculosis. While multidrug treatment regimens are the standard of care, the lengthy treatment schedule and ...

Mammalian hosts coordinate various cell death pathways as part of the immune defense system against pathogens including ...

The tuberculosis outbreak in the Kansas City area is not, in fact, the largest in U.S. history. But it does offer an ...

Every year, 10 million people contract tuberculosis (TB), a disease caused by the bacterium Mycobacterium tuberculosis (Mtb), and approximately 1.5 million patients succumb to the disease. Treatment ...

David Ussery and Brian Delavan discuss bioinformatics into TB surveillance, presenting a new approach to tackling this ...

Rifampicin (RFP) is used for the treatment of chronic bone tuberculosis owing to its powerful and wide ... was optimized using the encapsulation rate as an indicator and the morphology, mean particle ...

Infection with Mycobacterium tuberculosis (Mtb) triggers an autoimmune-like response ... Mtb and human macrophages by utilizing micropatterning to standardize macrophage morphology and organelle ...

Tuberculosis, or TB, is a bacterial infection that primarily affects the lungs but can also spread to other parts of the body. It;s transmitted through the air when someone with TB coughs ...

Health officials are raising the alarm over a large and ongoing tuberculosis (TB) outbreak in Kansas. According to data from the Kansas Department of Health and Environment (KDHE), the cases have ...